We present the results of a global coma morphology campaign for comet C/2012 S1 (ISON), which was organized to involve both professional and amateur observers. In response to the campaign, many hundreds of images, from nearly two dozen groups were collected. Images were taken primarily in the continuum, which help to characterize the behavior of dust in the coma of comet ISON. The campaign received images from January 12 through November 22, 2013 (an interval over which the heliocentric distance decreased from 5.1 AU to 0.35 AU), allowing monitoring of the long-term evolution of coma morphology during comet ISON's pre-perihelion leg. Data were contributed by observers spread around the world, resulting in particularly good temporal coverage during November when comet ISON was brightest but its visibility was limited from any one location due to the small solar elongation. We analyze the northwestern sunward continuum coma feature observed in comet ISON during the first half of 2013, finding that it was likely present from at least February through May and did not show variations on diurnal time scales. From these images we constrain the grain velocities to ~10 m s -1 , and we find that the grains spent 2-4 weeks in the sunward side prior to merging with the dust tail. We present a rationale for the lack of continuum coma features from September until mid-November 2013, determining that if the feature from the first half of 2013 was present, it was likely too small to be clearly detected. We also analyze the continuum coma morphology observed subsequent to the November 12 outburst, and constrain the first appearance of new features in the continuum to later than November 13.99 UT.
These findings describe a mechanism for false-negative results from decreased posterior tracheal wall tone during cardiac arrest. Further studies are required to elucidate factors contributing to its occurrence and impact on EDD use.
While scholars recognize that cause lawyers use public education as a reform tactic, they rarely place this tactic at the center of their analysis, leaving a gap in our understanding of how cause lawyers use extrajudicial tactics to navigate the limits of litigation. In this article, I examine the role of public education in the work of cause lawyers, through a study of lawyers from eight legal organizations representing the rights of LGBTQ people. Through interviews, archival work, and analysis of publications, I find that lawyers and organizations use education for four functions: (1) to prime a pathway to successful litigation; (2) to control for backlash; (3) to leverage pressure during litigation or policy negotiation; and (4) to generate community and public awareness. This article shows that public education is not simply an ancillary tool to these groups—it is vital to their missions and their everyday work.
Sarcoidosis is a multisystem granulomatous disease that affects 10 to 20 people per 100,000 in the United States. Hypercalcemia is a known side effect of the disease and in rare instances has been shown to cause ST-segment elevation on electrocardiogram testing that mimics myocardial infarction. Herein, we present a rare case of a 55-year-old, asymptomatic African-American male with sarcoidosis and hydrochlorothiazide usage presenting with ST-segment elevation of the anterior leads secondary to hypercalcemia. Urgent cardiac catheterization showed normal coronary arteries without blockage. The patient's hypercalcemia was corrected with intravenous fluids and the ST-segment elevation resolved. The exact mechanism of ST-segment elevation induced hypercalcemia is unknown. Treatment of the underlying cause of the hypercalcemia is the mainstay of therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.